- Filed
- Jun 27, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Jun 27, 2024 | 3.31M sh |
| Shares Diluted | FY 2024 · Mar 31, 2023 | 21.04M sh |
| Capex | FY 2024 · Mar 31, 2023 | $0 |
| Operating Cash Flow restated | FY 2024 · Mar 31, 2023 | −$306K |
| Short Term Investments | FY 2024 · Mar 31, 2023 | $0 |
| Cash And Equivalents | FY 2024 · Mar 31, 2023 | $25.27M |
| Current Liabilities | FY 2024 · Mar 31, 2023 | $4.65M |
| Total Liabilities | FY 2024 · Mar 31, 2023 | $5.91M |
| Current Assets | FY 2024 · Mar 31, 2023 | $31.1M |
| Total Assets | FY 2024 · Mar 31, 2023 | $31.37M |
| Eps Diluted | FY 2024 · Mar 31, 2023 | −$0.06 |
| Eps Basic | FY 2024 · Mar 31, 2023 | −$0.06 |
| Sga Expense | FY 2024 · Mar 31, 2023 | $4.2M |
| Net Income | FY 2024 · Mar 31, 2023 | −$1.36M |
| Operating Income | FY 2024 · Mar 31, 2023 | −$2.1M |
| Cost Of Revenue | FY 2024 · Mar 31, 2023 | $5.08M |
| Revenue | FY 2024 · Mar 31, 2023 | $7.18M |
| Stockholders Equity | FY 2024 · Mar 31, 2022 | $26.82M |